Millennium Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-325,237
| Closed | -$413K | – | 5001 |
|
|
2023
Q3 | $413K | Buy |
325,237
+199,402
| +158% | +$253K | ﹤0.01% | 3336 |
|
|
2023
Q2 | $41K | Sell |
125,835
-330,514
| -72% | -$108K | ﹤0.01% | 3986 |
|
|
2023
Q1 | $196K | Sell |
456,349
-103,789
| -19% | -$44.6K | ﹤0.01% | 3868 |
|
|
2022
Q4 | $297K | Sell |
560,138
-37,462
| -6% | -$19.9K | ﹤0.01% | 3921 |
|
|
2022
Q3 | $437K | Buy |
597,600
+294,049
| +97% | +$215K | ﹤0.01% | 3941 |
|
|
2022
Q2 | $346K | Buy |
+303,551
| New | +$346K | ﹤0.01% | 4138 |
|
|
2021
Q4 | – | Sell |
-387,602
| Closed | -$1.64M | – | 5878 |
|
|
2021
Q3 | $1.64M | Sell |
387,602
-852
| -0.2% | -$3.61K | ﹤0.01% | 3214 |
|
|
2021
Q2 | $2.06M | Buy |
388,454
+366,074
| +1,636% | +$1.94M | ﹤0.01% | 3122 |
|
|
2021
Q1 | $104K | Buy |
+22,380
| New | +$104K | ﹤0.01% | 4305 |
|
|
2020
Q4 | – | Sell |
-197,080
| Closed | -$652 | – | 4497 |
|
|
2020
Q3 | $652 | Sell |
197,080
-17,723
| -8% | -$59 | ﹤0.01% | 2729 |
|
|
2020
Q2 | $724K | Buy |
+214,803
| New | +$724K | ﹤0.01% | 2557 |
|
|
2019
Q4 | – | Sell |
-23,336
| Closed | -$176K | – | 3884 |
|
|
2019
Q3 | $176K | Buy |
23,336
+5,479
| +31% | +$41.3K | ﹤0.01% | 3175 |
|
|
2019
Q2 | $242K | Sell |
17,857
-2,853
| -14% | -$38.7K | ﹤0.01% | 3124 |
|
|
2019
Q1 | $112K | Sell |
20,710
-9,894
| -32% | -$53.5K | ﹤0.01% | 3296 |
|
|
2018
Q4 | $91K | Sell |
30,604
-123,299
| -80% | -$367K | ﹤0.01% | 3163 |
|
|
2018
Q3 | $1.26M | Sell |
153,903
-70,608
| -31% | -$576K | ﹤0.01% | 2415 |
|
|
2018
Q2 | $2.19M | Buy |
224,511
+120,570
| +116% | +$1.17M | ﹤0.01% | 2059 |
|
|
2018
Q1 | $903K | Buy |
+103,941
| New | +$903K | ﹤0.01% | 2542 |
|
|
2017
Q3 | – | Sell |
-16,772
| Closed | -$285K | – | 3614 |
|
|
2017
Q2 | $285K | Sell |
16,772
-14,526
| -46% | -$247K | ﹤0.01% | 2822 |
|
|
2017
Q1 | $629K | Buy |
+31,298
| New | +$629K | ﹤0.01% | 2457 |
|